BioMarin Presents 15 Abstracts From Basic Research to Clinical Trials at Lysosomal Disease Network’s 10th Annual WORLDSymposium(TM)

[GlobeNewswire] – 12 Abstracts on MPS diseases and 3 on Pompe Disease 10-Year Naglazyme(R) (galsulfase) Data Suggests Increased Survival of MPS VI Patients more

View todays social media effects on BMRN

View the latest stocks trending across Twitter. Click to view dashboard

See who BioMarin is hiring next, click here to view